Staphylococcus Aureus clinical trials

Explore recruiting staphylococcus aureus clinical trials.

Recruiting staphylococcus aureus studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Staphylococcus Aureus trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PhagoDAIR I : A Pilot, Multicenter, Randomized, Non Comparative, Double-Blind Study of Phage Therapy in Patients with Hip or Knee Prosthetic Joint Infection due to Staphylococcus aureus Treated with DAIR and Antibiotic Therapy.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 1 study in Staphylococcus aureus endocarditis

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Staphylococcus aureus Network Adaptive Platform trial (SNAP)

Netherlands, Germany, Sweden, France

Therapeutic use (Phase IV) EU CTIS Study details

Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterrelated bloodstream infections due to Staphylococcus aureus [DALICATH]

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Staphylococcus aureus Network Adaptive Platform trial (SNAP)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Treatment of penicillin susceptible Staphylococcus aureus bacteraemia with bensylpenicillin versus cloxacillin – a randomized controlled trial

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Staphylococcus Aureus trials by city

Staphylococcus Aureus clinical trials

Recruiting staphylococcus aureus studies right now

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP

Linezolid Plus Standard of Care

Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis

Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial

Rapid De-escalation of Anti-MRSA Therapy Guided by S. Aureus Nares Screening in Case of Pneumonia

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

Comparison of Cloxacillin and Benzylpenicillin in Penicillin Susceptible S. Aureus Bacteraemia

Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3

Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment

Target Attainment of Continuous Infusion Flucloxacillin and Cefazolin Coupled With TDM vs. Standard of Care Treatment in Patients With Complicated S. Aureus Infection

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Also recruiting in Europe

PhagoDAIR I : A Pilot, Multicenter, Randomized, Non Comparative, Double-Blind Study of Phage Therapy in Patients with Hip or Knee Prosthetic Joint Infection due to Staphylococcus aureus Treated with DAIR and Antibiotic Therapy.

Phase 1 study in Staphylococcus aureus endocarditis

Staphylococcus aureus Network Adaptive Platform trial (SNAP)

Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterrelated bloodstream infections due to Staphylococcus aureus [DALICATH]

Staphylococcus aureus Network Adaptive Platform trial (SNAP)

Treatment of penicillin susceptible Staphylococcus aureus bacteraemia with bensylpenicillin versus cloxacillin – a randomized controlled trial

Staphylococcus Aureus trials by city

Other conditions